Filters
Results: 1 to 6 of 6
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Leukodystrophy and Leukoencephalopathy Panel PreventionGenetics, part of Exact Sciences United States | 202 | 212 |
|
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel PreventionGenetics, part of Exact Sciences United States | 239 | 158 |
|
Comprehensive Neuromuscular Panel PreventionGenetics, part of Exact Sciences United States | 376 | 266 |
|
Dystroglycanopathy via the DAG1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Congenital Muscular Dystrophy (CMD) Panel PreventionGenetics, part of Exact Sciences United States | 34 | 28 |
|
Dystroglycan-Related Congenital Muscular Dystrophy Panel PreventionGenetics, part of Exact Sciences United States | 22 | 18 |
|
Results: 1 to 6 of 6
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.